Participants were randomly assigned ( 1:1 ) via computer-generated blocked randomisation , stratified by centre and tumour type , to receive either imiquimod 5 % cream once daily for 6 weeks ( superficial ) or 12 weeks ( nodular ) , or surgical excision with a 4 mm margin .